Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile
Neeraj Agarwal, MD, FASCO

@neerajaiims

Medical Oncologist. Editor-in-chief: @ASCO Daily News; Presidential Endowed Chair, @HuntsmanCancer (NCI-CCC) @UUtah, FCOI bit.ly/3A3u2KL

ID: 4761682514

linkhttps://bit.ly/3JApRJd calendar_today15-01-2016 06:32:10

13,13K Tweet

15,15K Takipçi

770 Takip Edilen

Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo
Neeraj Agarwal, MD, FASCO
@neerajaiims

a year ago

Just in Annals of Oncology 👉on the heels of the recent approval of belzutifan in mRCC #kidneycancer , herein we show in a ph2 randomized trial👉more belzutifan (200 mg vs 120 mg QD) was not better👇Link: tinyurl.com/nrsxp8s4 UroToday.com OncoAlert KidneyCAN Huntsman Cancer Institute

Just in <a href="/Annals_Oncology/">Annals of Oncology</a> 👉on the heels of the recent approval of belzutifan in mRCC #kidneycancer , herein we show in a ph2 randomized trial👉more belzutifan (200 mg vs 120 mg QD) was not better👇Link: tinyurl.com/nrsxp8s4 <a href="/urotoday/">UroToday.com</a> <a href="/OncoAlert/">OncoAlert</a> <a href="/kidneycan/">KidneyCAN</a> <a href="/huntsmancancer/">Huntsman Cancer Institute</a>